Evidence map›Paper›PMID 23222914›Full record

ArticleNature neuroscience2013

A role for Schwann cell-derived neuregulin-1 in remyelination.

Ruth M Stassart, Robert Fledrich, Viktorija Velanac, Bastian G Brinkmann, Markus H Schwab, Dies Meijer, Michael W Sereda, Klaus-Armin Nave

Registry-linked trialOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07308275 (Longitudinal Evaluation of Direct Neurotization Technique in Breast Reconstruction With Fully Autologous Components), which is not on this map. Cited by 162 papers.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07308275 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Longitudinal Evaluation of Direct Neurotization Technique in Breast Reconstruction With Fully Autologous Components: An Assessment of BREAST-Q Sensation Module, Cutaneous Pressure Threshold, Neuregulin 1 (NRG1) Expression, Nerve Fiber Cross-sectional Area, Intraepidermal Nerve Fiber Density (IENFD), and Breast Morphometry

TypeinterventionalSponsorFakultas Kedokteran Universitas IndonesiaRan2025 to 2027Enrolled28ConditionsBreast Reconstruction After Mastectomy, Neurotization, Mastectomy and Breast Reconstruction, Peripheral Nerve RegenerationArmsAutologous Breast Reconstruction With Direct Neurotization, Autologous Breast Reconstruction without Neurotization
3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 289 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Myelin development in the peripheral nervous system ofFrontiers in cell and developmental biology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Basic Pathological Mechanisms in Peripheral Nerve Diseases.International journal of molecular sciences · 2025
    Review
  14. Review
  15. Article
  16. Review
  17. Dynamic regulation ofFrontiers in cell and developmental biology · 2025
    Article
  18. Article
  19. Article
  20. Role of theBiomedicines · 2024
    Article

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Ruth M StassartMax Planck Institute of Experimental Medicine, Department of Neurogenetics, Göttingen, Germany.
Robert Fledrich
Viktorija Velanac
Bastian G Brinkmann
Markus H Schwab
Dies Meijer
Michael W Sereda
Klaus-Armin Nave
Max Planck Institute of Experimental Medicine · DEMax Planck Society · DECharité - Universitätsmedizin Berlin · DEErasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After peripheral nerve injury, axons regenerate and become remyelinated by resident Schwann cells. However, myelin repair never results in the original myelin thickness, suggesting insufficient stimulation by neuronal growth factors. Upon testing this hypothesis, we found that axonal neuregulin-1 (NRG1) type III and, unexpectedly, also NRG1 type I restored normal myelination when overexpressed in transgenic mice. This led to the observation that Wallerian degeneration induced de novo NRG1 type I expression in Schwann cells themselves. Mutant mice lacking a functional Nrg1 gene in Schwann cells are fully myelinated but exhibit impaired remyelination in adult life. We suggest a model in which loss of axonal contact triggers denervated Schwann cells to transiently express NRG1 as an autocrine/paracrine signal that promotes Schwann cell differentiation and remyelination.

Indexed as

AnimalsAnimals, NewbornAxonsCell ProliferationCells, CulturedCulture Media, ConditionedDemyelinating DiseasesDisease Models, AnimalEarly Growth Response Protein 2Electric StimulationEnzyme InhibitorsEvoked Potentials, MotorGanglia, SpinalGene Expression RegulationHedgehog ProteinsKi-67 AntigenCulture Media, ConditionedEarly Growth Response Protein 2Egr2 protein, mouseEnzyme InhibitorsHedgehog ProteinsKi-67 AntigenMpz protein, mouseMyelin Basic ProteinMyelin P0 ProteinNAV1.6 Voltage-Gated Sodium ChannelNeuregulin-1Nrg1 protein, mouseOctamer Transcription Factor-6Pou3f1 protein, mouseRNA, MessengerS100 ProteinsScn8a protein, mouse

Identifiers

PMID23222914
OpenAlexW1966476265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.